Clinical Trial

A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma

Name: A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma — clinical trial record (NCT07338968)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CoMpass

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

AU-011-403 is a multicenter long-term follow-up safety and efficacy study of subjects with early CM who previously participated in the AU-011-301 Phase 3 trial. There are no required interventions or use of AU-011 (bel-sar) in this long-term follow-up study

Trial Details

NCT Number	NCT07338968
Lead Sponsor	Aura Biosciences
Conditions	Choroidal Melanoma, Indeterminate Lesions
Enrollment	100 participants
Start Date	2026-02-01
Primary Completion	2033-08-15 (estimated)
Study Completion	2033-08-15 (estimated)
Updated on ClinicalTrials.gov	2026-01-14